Back
MoonLake Immunotherapeutics Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Buy
54
MLTX
MoonLake Immunotherapeutics
Last Price:
$44.16
Seasonality Move:
33.34%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
The current trend is moderately bullish and MLTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.48 | Sell |
| 20-day SMA: | 42.47 | Buy |
| 50-day SMA: | 39.97 | Buy |
| 200-day SMA: | 45.67 | Sell |
| 8-day EMA: | 44.84 | Sell |
| 20-day EMA: | 43.29 | Buy |
| 50-day EMA: | 41.58 | Buy |
| 200-day EMA: | 43.7 | Buy |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.69 | Buy |
| Relative Strength Index (14 RSI): | 54.87 | Buy |
| Chaikin Money Flow: | 220972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.53 - 45.77) | Buy |
| Bollinger Bands (100): | (37.42 - 44.56) | Buy |
MoonLake Immunotherapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 44.21 while MLTX 8-day simple moving average is 46.48, which is a Sell signal.
-
The stock price of MLTX is 44.21 while MoonLake Immunotherapeutics 20-day SMA is 42.47, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day simple moving average is 39.97 while MLTX share price is 44.21, making it a Buy technically.
-
MLTX stock price is 44.21 and MoonLake Immunotherapeutics 200-day simple moving average is 45.67, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Buy
54
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a BuyThe current MoonLake Immunotherapeutics [MLTX] share price is $44.21. The Score for MLTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
2.8B
Price in USD:
44.21
Share Volume:
316.3K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
58.26
52-Week Low:
31.42
Buy
54
MoonLake Immunotherapeutics (MLTX)
is a Buy
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 44.21 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is not overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 44.21 while MLTX 8-day exponential moving average is 44.84, which is a Sell signal.
-
The stock price of MLTX is 44.21 while MoonLake Immunotherapeutics 20-day EMA is 43.29, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 41.58 while MLTX share price is 44.21, making it a Buy technically.
-
MLTX stock price is 44.21 and MoonLake Immunotherapeutics 200-day simple moving average is 43.70, creating a Buy signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is 1.69, suggesting MoonLake Immunotherapeutics is a Buy
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 54.87, which suggest MoonLake Immunotherapeutics is overbought
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (37.53 - 45.77), which suggest MoonLake Immunotherapeutics is a Buy
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (37.42 - 44.56), which suggest MoonLake Immunotherapeutics is a Buy
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.